Article info

Download PDFPDF

Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease

Authors

  • Lukas Sprenger VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaDepartment of Medicine I, Academic Teaching Hospital Feldkirch, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  • Arthur Mader VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaDepartment of Medicine I, Academic Teaching Hospital Feldkirch, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  • Barbara Larcher VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaDepartment of Medicine I, Academic Teaching Hospital Feldkirch, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  • Maximilian Mächler VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaDepartment of Medicine I, Academic Teaching Hospital Feldkirch, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  • Alexander Vonbank VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaDepartment of Medicine I, Academic Teaching Hospital Feldkirch, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  • Daniela Zanolin-Purin VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  • Andreas Leiherer VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  • Axel Muendlein VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  • Heinz Drexel VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, LiechtensteinDrexel University College of Medicine, Philadelphia, Pennsylvania, USADepartment of Medicine, County Hospital Bregenz, Bregenz, Vorarlberg, Austria PubMed articlesGoogle scholar articles
  • Christoph H Saely VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, AustriaDepartment of Medicine I, Academic Teaching Hospital Feldkirch, Feldkirch, Vorarlberg, AustriaPrivate University in the Principality of Liechtenstein, Triesen, Liechtenstein PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Christoph H Saely; christoph.saely{at}icloud.com
View Full Text

Citation

Sprenger L, Mader A, Larcher B, et al
Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease

Publication history

  • Received May 27, 2021
  • Accepted September 18, 2021
  • First published November 15, 2021.
Online issue publication 
November 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.